Webb11 dec. 2014 · There is an increased risk of myopathy associated with high-dose (80 mg) simvastatin. The 80-mg dose should be considered only in patients with severe … Webb16 juni 2024 · For diabetics without ASCVD, use MODERATE INTENSITY statin for primary prevention 1. For diabetics “with” ASCVD, use HIGH INTENSITY statin for secondary prevention 2. Low Intensity statins are not recommended unless unable to tolerate moderate or high intensity. References: Cochrane Database Syst Rev. 2013:CD004816
Statin intensity and risk for cardiovascular events after heart ...
WebbAdvantage MD, EHP, Priority Partners, and USFHP. Males 21-75 years of age; Females 40-75 years of age. The percentage of males 21-75 years of age and females 40-75 years of … Webb2. Statin therapy has shown clear benefits and is recommended in four major groups of patients (strong evidence): 1,2. Patient Group Recommended Intensity of Statin Treatment Clinical ASCVD* Age ≤ 75 years with no statin-related safety concerns † a High Age > 75 years or with statin-related safety concerns Moderate . LDL . ≥ 190 mg/dL ... eagle alloy off road wheels
HIGH, MODERATE AND LOW INTENSITY STATIN MEDICATIONS
Webb21 okt. 2016 · The dose of simvastatin should be limited to 20 mg daily when coprescribed with ranolazine, and doses above this limit are not recommended. Coadministration of … WebbStatins include atorvastatin (Lipitor), fluvastatin (Lescol XL), lovastatin (Altoprev), pitavastatin (Livalo), pravastatin (Pravachol), rosuvastatin (Crestor, Ezallor) and … Webb12 apr. 2024 · Moderate-intensity statin with ezetimibe combination therapy was associated with lower rates of intolerance-related drug discontinuation or dose reduction among patients aged ≥75 years (2.3% vs. 7.2%; p = 0.010) and those aged <75 years (5.2% vs. 8.4%; p < 0.001) (p for interaction = 0.159). eagle alloy polished aluminum wheels